Search Within

Chau Dang

Formats
  1. Journal Article (132)
  2. Meeting Abstract (122)
  3. Guidelines (8)
  4. Book Section (4)
  5. Review (3)
  6. Book Whole (1)
  7. Editorial (1)
  8. Miscellaneous (1)
  9. Research Letter (1)
Groups
  1. Breast Medicine Service (273)
  2. Department of Medicine (273)
  3. Solid Tumor Oncology Division (273)
  4. Survivorship Research (273)
  5. Population Sciences Research Program (119)
  6. Epidemiology and Biostatistics (93)

More Groups

People
  1. Clifford Hudis (111)
  2. Larry Norton (76)
  3. Richard Steingart (49)
  4. Anthony Yu (46)
  5. Shanu Modi (42)
  6. Sujata Patil (41)

More People

Years
  1. 2025 (4)
  2. 2024 (12)
  3. 2023 (15)
  4. 2022 (18)
  5. 2021 (12)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (68)
  2. Cancer Research (42)
  3. Breast Cancer Research and Treatment (23)
  4. Annals of Oncology (10)
  5. Clinical Breast Cancer (7)
  6. Clinical Cancer Research (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (70)
  2. American Association for Cancer Research (50)
  3. Springer (33)
  4. Oxford University Press (22)
  5. Elsevier Inc. (16)
  6. American Medical Association (11)

More Publishers

Results (273)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of the 2018 ASCO/CAP HER2 guideline updates on HER2 assessment in breast cancer with HER2 immunohistochemistry equivocal results
    Meeting Abstract

    Wen, H.; Ventura, K.; Xu, J.; Ross, D.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Brogi, E.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Phase Ib/II study of capecitabine 7/7 schedule with neratinib in patients with HER2-positive metastatic breast cancer (MBC)
    Meeting Abstract

    Wang, R.; Singh, J.; Sterlin, V.; Goldstein, M.; Lake, D.; Wong, S.; Baselga, J.; Norton, L.; Dang, C.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • The impact of breast cancer surgery on quality of life: Long term results from E5103
    Meeting Abstract

    Rosenberg, S. M.; O'Neill, A.; Sepucha, K.; Miller, K. D.; Dang, C. T.; Northfelt, D. W.; Sledge, G. W.; Schneider, B. P.; Partridge, A. H.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Transient state change, but not permanent subtype change, after HER2-targeted therapy for HER2-positive breast cancer
    Meeting Abstract

    Tanioka, M.; Parker, J. S.; Henry, L. N.; Tolaney, S.; Dang, C.; Krop, I. E.; Harris, L.; Polley, M.; Berry, D. A.; Winer, E. P.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with human epidermal growth receptor 2 overexpressing metastatic breast cancer: 5-year follow-up
    Journal Article

    Wang, R.; Smyth, L. M.; Iyengar, N.; Chandarlapaty, S.; Modi, S.; Jochelson, M.; Patil, S.; Norton, L.; Hudis, C. A.; Dang, C. T.
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy
    Journal Article

    Krystel-Whittemore, M.; Xu, J.; Brogi, E.; Ventura, K.; Patil, S.; Ross, D. S.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; more...
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save
  • Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: The SAFE-HEaRt study
    Journal Article

    Lynce, F.; Barac, A.; Geng, X.; Dang, C.; Yu, A. F.; Smith, K. L.; Gallagher, C.; Pohlmann, P. R.; Nunes, R.; Herbolsheimer, P.; more...
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save
  • Local–regional recurrence in women with small node-negative, HER2-positive breast cancer: Results from a prospective multi-institutional study (the APT trial)
    Journal Article

    Bellon, J. R.; Guo, H.; Barry, W. T.; Dang, C. T.; Yardley, D. A.; Moy, B.; Marcom, P. K.; Albain, K. S.; Rugo, H. S.; Ellis, M.; more...
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save
  • The immune profile of small HER2-positive breast cancers: A secondary analysis from the APT trial
    Journal Article

    Barroso-Sousa, R.; Barry, W. T.; Guo, H.; Dillon, D.; Tan, Y. B.; Fuhrman, K.; Osmani, W.; Getz, A.; Baltay, M.; Dang, C.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fraction
    Journal Article

    Hussain, Y.; Drill, E.; Dang, C. T.; Liu, J. E.; Steingart, R. M.; Yu, A. F.
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save